Medicinal Products

Myfortic 180 mg želučanootporne tablete

Name Myfortic 180 mg želučanootporne tablete
Marketing Authorisation Number HR-H-505070647
Active Substance acidum mycophenolicum
Composition jedna želučanootporna tableta sadrži 180 mg mikofenolatne kiseline u obliku natrijevog mikofenolata
Pharmaceutical Form želučanootporna tableta
Packaging [MA Number for Packaging] 120 tableta u blisteru, u kutiji  [HR-H-505070647-01]
Manufacturer Novartis Pharma GmbH, Nürnberg, Njemačka
Lek Pharmaceuticals d.d., Lendava, Slovenija
Marketing Authorisation Holder Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska
Marketing Authorisation Date 19.10.2015
MA Period of Validity unlimited
Classification Number UP/I-530-09/14-02/381
Registration Number 381-12-01/70-15-05
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code L04AA06
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Educational materials
for healthcare professionals
Upitnik za zdravstvene radnike, verzija 1
Obrazac za prijavu i praćenje trudnoće za zdravstvene radnike, verzija 1
Vodič za zdravstvene radnike, verzija 2
Educational materials
for patients / caregivers
Upitnik za bolesnike, verzija 1
Vodič za bolesnike, verzija 2

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o izmijenjenim preporukama za kontracepciju povezanim s primjenom mofetilmikofenolata/mikofenolatne kiseline (CellCept, Myfortic, Trixin) 22.01.2018 Roche d.o.o., Novartis Hrvatska d.o.o., Pliva Hrvatska d.o.o.
Back